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Edited by Veli-Pekka LehtoAbstract A number of regulatory factors including dietary
iron levels can dramatically alter the expression of the intesti-
nal iron transporter DMT1. Here we show that Caco-2 cells
exposed to iron for 4 h exhibited a signiﬁcant decrease in plas-
ma membrane DMT1 protein, though total cellular DMT1
levels were unaltered. Following biotinylation of cell surface
proteins, there was a signiﬁcant increase in intracellular bio-
tin-labelled DMT1 in iron-exposed cells. Furthermore, iron-
treatment increased levels of DMT1 co-localised with
LAMP1, suggesting that the initial response of intestinal epi-
thelial cells to iron involves internalisation and targeting of
DMT1 transporter protein towards a late endosomal/lysosomal
compartment.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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An adequate dietary supply of iron is essential both to
maintain red blood cell production and for the normal func-
tion of a number of key metabolic enzymes. The Western diet
provides roughly 10 mg of iron per day from which 1 mg per
day is absorbed to replace the iron that is lost through bleed-
ing and from epithelial cells when they are shed from the sur-
face of the gastrointestinal and urinary tracts. The absorption
of dietary iron is facilitated by a co-ordinated transport path-
way that exists in intestinal epithelial cells (reviewed in [1]).
Since both elevated and impaired absorption of iron can lead
to serious health problems, the assimilation of iron from the
diet is tightly regulated by signals generated at the bodys
main sites of storage (the liver) and utilisation (the bone mar-Abbreviations: DMT1, divalent metal transporter 1; Dcytb, duodenal
cytochrome b; EEA1, early endosomal antigen 1; HEPES, N-2-hy-
droxyethylpiperazine-N 0-2-ethanesulfonic acid; IRE, iron responsive
element; IREG1, iron regulated transporter 1; LAMP1, lysosome ass-
ociated membrane protein 1; PBS, phosphate-buﬀered saline; PCR,
polymerase chain reaction
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throid regulator, respectively. Together, these regulatory
pathways match intestinal iron uptake to the bodys meta-
bolic requirements. Hepcidin, a 20–25 amino acid peptide
produced in the liver [2,3], is thought to fulﬁl both of these
regulatory roles, relaying information to the duodenum
regarding liver iron levels [4] as well as the iron requirements
for red blood cell production [5], to maintain body iron
homeostasis.
In addition to humoral regulation, intestinal iron absorp-
tion is also controlled by a number of dietary factors includ-
ing iron itself. It has been known for many years that a large
oral dose of iron can reduce subsequent iron absorption (re-
viewed in [6]). Recent studies have shown that this so-called
‘‘mucosal block’’ is mediated by a decrease in the mRNA
expression of the apical membrane transporter DMT1 and
the ferric reductase Dcytb [7]. While changes in transporter
protein expression were not measured in this previous study,
subsequent evidence suggests that following the acute admin-
istration of an iron bolus [8] or in chronically iron-loaded
animals [9], DMT1 protein appears to be localised intracellu-
larly. Furthermore, our own work in Caco-2 cells has shown
that exposure to iron, at doses well within the dietary range,
decreases apical membrane expression of DMT1 [10]. Intrigu-
ingly, in our study, total cellular DMT1 protein was unal-
tered suggesting that the response to increasing levels of
iron involves transporter redistribution. The purpose of the
present study was to establish the timecourse for these iron-
mediated events and to determine the fate of DMT1 follow-
ing exposure to iron.2. Materials and methods
2.1. Cell culture
Caco-2 cells (the TC7 subclone – obtained from Drs. Monique
Rousset and Edith Brot-Laroche, Inserm U505, Paris France) were
cultured in a 95% air/5% CO2 atmosphere in Dulbeccos modiﬁed Ea-
gles minimal essential medium (DMEM), supplemented with 20%
heat-inactivated fetal bovine serum. All experiments were carried out
on cells (passage numbers 30–42) 21 days post-seeding. For the ﬁnal
24 h of the culture period, the cells were placed in serum-free medium.
On the day of experimentation, fresh serum-free medium (±100 lM
ferric ammonium citrate) was applied to the cells for between 1 and
24 h.
2.2. Confocal microscopy
Caco-2 cells grown on semi-permeable membranes were ﬁxed and
permeabilised for 30 min in phosphate-buﬀered saline (PBS) contain-
ing 4% (w/v) paraformaldehyde and 0.1% (v/v) Triton X-100.blished by Elsevier B.V. All rights reserved.
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for 2 h at room temperature with an aﬃnity-puriﬁed anti-
DMT1(+IRE) antibody (Alpha Diagnostics Inc., San Antonio, TX,
USA; 1 lg/ml). A TRITC-labelled secondary antibody was employed
to visualise cross-reactivity. Images were captured using a Zeiss LSM
510 confocal microscope and processed using the manufacturers ded-
icated LSM Software.Fig. 1. DMT1(+IRE) protein is expressed at the apical surface of
Caco-2 cells. Cells, cultured on Transwell inserts, were probed with an
antibody that recognises the IRE-containing isoforms of DMT1.
Confocal microscopy, both focussing on the apical membrane (a) and
taking an image through the z-plane of the monolayer (b) revealed that
DMT1(+IRE) was predominantly expressed at the apical surface of
the polarised Caco-2 monolayer.2.3. Biotinylation of cell surface proteins
Cells were washed twice with PBS and exposed to EZ-link Sulfo-
NHS-SS-biotin (Perbio Science UK Ltd., Cramlington, Northumber-
land, UK) (300 lg/ml in PBS) for 30 min at 4 C. Following removal
of excess biotin, by washing with PBS, cells were placed in serum-free
medium (±100 lM Fe) and incubated at 37 C for 4 h. At the end of
the incubation period, cells were washed twice in glutathione-strip buf-
fer (50 mM glutathione, 75 mM NaCl, 55 mM NaOH and 10% fetal
bovine serum) and twice more with iodoacetamide buﬀer (50 mM
iodoacetamide in PBS) to remove excess biotin from the cell surface
and quench its activity, respectively. Cell monlayers were placed on
ice and lysed with ice-cold RIPA lysis buﬀer (150 mM NaCl, 10 mM
Tris (pH 8), 1 mM EDTA, 1%NP-40, 0.1% SDS, 0.5 mM PMSF,
0.2 mM benzamidine and 0.02% NaN3). Nuclei and plasma mem-
branes were precipitated by centrifugation (12000 · g for 10 min)
and the supernatant incubated for 1 h with either DMT1(+IRE) or
DMT1(non-IRE) antibodies and Protein-A Sepharose to precipitate
DMT1 transporter proteins.
2.4. Subcellular fractionation
Fully diﬀerentiated Caco-2 cells were washed in PBS and harvested
using a cell scraper. Following a short centrifugation step (800 · g for
5 min), cells were resuspended in sucrose homogenisation buﬀer
(300 mM sucrose and 10 mM N-2-hydroxyethylpiperazine-N 0-2-
ethanesulfonic acid (HEPES), pH 7.3) and homogenised with 10
strokes in a Potter homogeniser. The homogenate was centrifuged at
1500 · g for 10 min and the resulting supernatant layered onto a linear
sucrose gradient (0.3–1.7 M). Following centrifugation at 100000 · g
in a SW28 rotor (Beckman Coulter UK Ltd., High Wycombe, Bucks,
UK) gradients were separated into 10 · 3 ml fractions. The fractions
were diluted with homogenisation buﬀer to give a total volume of
30 ml and membranes within each fraction were recovered by centrifu-
gation at 128000 · g.
In separate studies, to pinpoint the cellular localisation of DMT1,
whole cell lysates from iron-treated and control cells were immunopre-
cipitated with antibodies to the endosomal markers LAMP1 and
EEA1 (Santa Cruz Biotechnology Inc., CA, USA).
2.5. Western blot analysis
Plasma membranes, prepared by methods described previously [11],
subcellular fractions and immunoprecipitates were solubilised in sam-
ple buﬀer and subjected to SDS–PAGE. The proteins were transferred
onto nitrocellulose (Hybond ECL; Amersham Pharmacia Biotech,
Buckinghamshire, UK) and blocked overnight in phosphate buﬀer
containing 0.05% Tween 20 and 1% fat-free milk. The nitrocellulose
was incubated for 2 h at room temperature with commercially avail-
able polyclonal antibodies to DMT1 (either with an antibody that
recognised all protein isoforms or with antibodies that were speciﬁc
to the iron responsive element (IRE) or the non-IRE isoforms – these
were designed to the C-terminal 17 or 22 amino acids, respectively,
which is where the protein sequences diﬀer [12]; Alpha Diagnostics
Inc.), LAMP1, EEA1 or villin (Santa Cruz). Following removal of
the primary antibody, nitrocellulose ﬁlters were incubated with the
appropriate HRP-linked secondary antibody, and cross-reactivity vis-
ualised using ECL Plus and Hyperﬁlm ECL (Amersham Pharmacia
Biotech) according to the manufacturers instructions. Band densities
were semi-quantiﬁed using Scion Image software (Scion Corporation,
Frederick, MD, USA).
2.6. Real-time polymerase chain reaction (PCR)
Iron transporter transcripts were analysed by real-time PCR using
LightCycler Fast Start DNA Master SYBR Green 1 (Roche Diagnos-
tics, Mannheim, Germany) on a LightCycler real-time PCR instrument
(version 3.5, Roche Diagnostics), according to the manufacturers pro-
tocol and using previously published primer sequences [13].2.7. Data analysis
Data are presented as means ± S.E.M. Statistical diﬀerences
(P < 0.05) between groups were determined using Students unpaired
t test or one-way analysis of variance (ANOVA) followed by Tukeys
post hoc test where appropriate.
2.8. Materials
Materials for Western blotting were supplied by Amersham Pharma-
cia Biotech Ltd. Cell culture medium, heat-inactivated fetal bovine ser-
um and plasticware were purchased from Invitrogen (Paisley, UK). All
other chemicals were of highest grade available and bought from Sig-
ma (Poole, Dorset, UK), Merck (Poole, Dorset, UK) or Fluka (Shaf-
tesbury, Dorset, UK).3. Results and discussion
The divalent metal transporter, DMT1, is responsible for the
uptake of non-haem iron from the intestinal lumen [14,15].
Our previous work (using an antibody that recognises all
DMT1 protein isoforms) demonstrated that DMT1 is also
the main iron transporter expressed at the apical surface of hu-
man intestinal Caco-2 cells where it mediates pH-dependent
Fe2+ uptake [16]. Complex processing of the DMT1 gene at
both the 3 0 [12] and the 5 0 ends [17] can give rise to four pos-
sible transporter variants. Not surprisingly therefore DMT1
protein expression has been observed at several cellular loca-
tions in a number of cells and tissues, including the intestine
[18–21]. The IRE-containing transcripts are predominantly ex-
pressed in the intestinal epithelium [12,17]. Consistent with
these ﬁndings, our current study demonstrated that
DMT1(+IRE) protein was expressed at the apical surface of
polarised Caco-2 cell monolayers (Fig. 1a and b). At this stage
it is unclear whether transcription starting in exon 1A or exon
1B of the DMT1 gene ultimately gives rise to the expressed
protein since RNA transcripts from both sites have been iden-
tiﬁed in Caco-2 cells [17].
Previous studies have indicated that both acute administra-
tion of iron (given as a bolus gavage) [7] and prolonged feeding
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and to changes in the cellular localisation of the protein [8,9].
Our earlier work with Caco-2 cells noted that iron induced a
dose-dependent decrease in DMT1 protein expression at the
plasma membrane though total cellular DMT1 protein levels
were unchanged [10]. These ﬁndings are also consistent with
cellular re-localisation of the transporter. In the present study,
we were interested to determine the timecourse for these
iron-mediated events since these changes might be relevant
physiologically in regulating iron absorption during the diges-
tive period. When Caco-2 cells were challenged with iron, a de-
crease in plasma membrane DMT1 protein expression was
observed that was maximal between 1 and 4 h and was sus-
tained in the presence of iron until the end of the experimental
period (24 h; Fig. 2a). Despite the dramatic decrease in mem-
brane DMT1 levels, total transporter protein expression was
unaltered over the 24 h incubation period (Fig. 2b), suggesting
that these events were due to redistribution of the transporter
between the plasma membrane and some intracellular loca-
tion. These initial studies employed an antibody that recogni-
sed all DMT1 protein isoforms. To determine whether both
the IRE and non-IRE variants were inﬂuenced by exposure
to iron, cells were incubated in iron-free (control) or iron-sup-
plemented medium for 4 h prior to plasma membrane isolationFig. 2. Membrane expression of DMT1 is decreased following exposure to i
blotting (using an antibody that recognises all DMT1 isoforms) revealed th
surface of Caco-2 cells (a). The decrease in transporter expression was maxim
the experimental period. In contrast, total cellular DMT1, measured by Weste
(b). Expression of the apical membrane-associated housekeeper protein vi
antibodies, following exposure to iron for 4 h there was a signiﬁcant decrease
control cells (c). In contrast, membrane levels of DMT1(non-IRE) were unal
treated cells compared with controls (e). Densitometry data are means ± S.E
above the data bars in panel (a) indicate that these groups are signiﬁcantly d
P < 0.05). *P < 0.01, Students unpaired t test.and Western blotting. Membrane levels of DMT1(+IRE) were
signiﬁcantly decreased in iron-treated cells compared with con-
trols (Fig. 2c). In contrast DMT1(non-IRE) levels were unal-
tered (Fig. 2d). Furthermore, the expression of the
basolateral iron eﬄux transport protein IREG1 (Fig. 2e) and
of villin, an apical membrane associated structural protein
[22] used as a housekeeper protein in these studies (Fig. 2a
and b), were not altered following acute (4 h) exposure to iron.
In addition, previous studies in our laboratory have shown
that IREG1 protein and mRNA expression are unaltered in
Caco-2 cells exposed for 24 h to iron (non-haem added to
the apical surface of the cells) compared with untreated con-
trols [10]. Taken together this evidence suggests that the eﬀects
of iron were speciﬁc to the DMT1(+IRE) protein. Similarly ra-
pid changes in DMT1 protein distribution have been observed
in rat intestine following administration of a bolus of iron indi-
cating that our observed eﬀects were not simply a cell culture
phenomenon [8]. Intriguingly, recent studies with Caco-2 cells
have demonstrated that addition of transferrin to the basolat-
eral surface of the monolayer also results in internalisation of
DMT1 away from the apical membrane [23]. Taken together
these ﬁndings suggest that internalisation of DMT1 may be
important in regulating the rate of iron ﬂux (from apical to ba-
sal) across this model epithelium.ron. Caco-2 cells were incubated with 100 lM Fe for 1–24 h. Western
at there was a signiﬁcant decrease in DMT1 expression at the apical
al by 4 h and remained low in the presence of iron for the remainder of
rn blotting of whole cell homogenates, was unaltered by iron-treatment
llin was also unaltered by iron (a, b). Using DMT1 isoform-speciﬁc
in plasma membrane DMT1(+IRE) protein expression compared with
tered (d). Furthermore, IREG1 protein levels were unchanged in iron-
.M. of four to six measurements at each time point. Diﬀerent letters
iﬀerent from each other (one-way ANOVA and Tukeys post hoc test,
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and mRNA expression showed that they did not follow the
same timecourse (Fig. 3). Following exposure to iron for 4 h,
when changes in membrane protein density were maximal
(Fig. 2a), there was no diﬀerence in mRNA expression of
DMT1 (in either the IRE-containing or the non-IRE variants).
However, by 24 h DMT1(+IRE) mRNA levels were signiﬁ-
cantly lower in the iron-treated group compared with the con-
trols. In contrast, the expression of the DMT1(non-IRE)
variant remained unaltered following 24 h iron treatment.
These data indicate that the initial cellular response to iron in-
volves a decrease in DMT1 protein in the apical membrane,
which occurs in advance of changes in transporter mRNA.
Down regulation of DMT1 mRNA by iron may require inac-
tivation of IRP-RNA binding, though this possibility is still
the subject of some controversy. While the IRE sequence con-
tained within the 3 0 untranslated region of DMT1 can bind
IRP in vitro [24,25] recent studies have questioned whether this





















Fig. 3. Eﬀect of iron on DMT1 mRNA expression. In contrast to the
rapid changes in DMT1 protein expression, DMT1 mRNA levels from
Caco-2 cells cultured in the presence or absence of 100 lM Fe were
unaltered after 4 h. 24 h incubation with iron signiﬁcantly decreased
mRNA expression of the IRE-containing transporter variants (ﬁlled
bars), whereas expression of the non-IRE variants remained un-
changed (open bars) compared with untreated control cells. Data are
means ± S.E.M. of six separate determinations. *P < 0.001 compared
with 0 h time point.
Fig. 4. DMT1(+IRE) protein is rapidly internalised following exposure to iro
cells were surface-labelled with biotin. Following removal of excess biotin, c
4 h. Post-plasma membrane lysates, adjusted to contain the same starting pro
(a) or DMT1(non-IRE) antibodies (b). Immunoprecipitated proteins were r
conjugate to identify biotinylated proteins. Higher levels of biotinylated DM
(a). In contrast, there was no increase in biotin-labelled non-IRE transporter l
three to four observations in each group. *P < 0.01 compared with control[26]. Interestingly, in this respect we have shown that regula-
tion of DMT1(+IRE) also occurs in Caco-2 cells exposed to
elevated levels of copper [27], indicating that the controlling
mechanisms are complex and not exclusively mediated by iron.
Rats administered a bolus dose of iron accumulate DMT1 in
intracellular vesicles [8]. However, it is not clear whether the
vesicular DMT1 is exclusively formed from protein interna-
lised from the plasma membrane or comprises newly synthes-
ised transporter. Therefore, to establish the fate of DMT1 in
our study, Caco-2 cell surface proteins were biotin-labelled
prior to iron treatment. After incubation with iron for 4 h
the cells were lysed and the intracellular contents subjected
to immunoprecipitation with either DMT1(+IRE) (Fig. 4a)
or DMT1(non-IRE) antibodies (Fig. 4b). While intracellular
levels of biotin-labelled DMT(+IRE) protein were increased
in iron-treated cells there was no corresponding increase in lev-
els of the non-IRE isoform, thus strengthening the argument
that the eﬀects of iron were isoform speciﬁc.
While the biotinylation studies further support the hypothe-
sis that iron exposure changes the cellular distribution of
DMT1(+IRE) protein, the precise intracellular localisation of
the internalised transporter is unclear. In previous work, with
both rat intestine and Caco-2 cells, DMT1 has been found in
endosomal fractions as well as at the cell surface [19,23]. A
more recent analysis looking at the transporter variants in a
number of cell lines indicated that intracellular DMT1(+IRE)
was predominantly localised to late endosomes and lysosomes,
whereas the non-IRE isoform co-localised with early endo-
somal fractions [28]. Our preliminary analysis in Caco-2 cells
conﬁrms this intracellular distribution for DMT1 (Fig. 5a).
Furthermore, when whole cell lysates, produced from cells
incubated in the presence or absence of iron for 4 h, were
immunoprecipitated with LAMP1 (a marker of late endo-
somes/lysosomes), subsequent immunoblotting demonstrated
that DMT1(+IRE) levels were signiﬁcantly increased in sam-
ples produced from the iron-treated cells (Fig. 5b). In contrast,
there was no change in the levels of DMT1(non-IRE) co-local-
ised with LAMP1 following iron treatment (Fig. 5c). In addi-
tion, analysis of EEA1 (an early endosomal antigen)
immunoprecipitates showed no diﬀerence in DMT1(+IRE)
protein expression between iron-treated and control cellsn. To determine the fate of DMT1 following exposure to iron, Caco-2
ells were exposed to either iron-supplemented or iron-free medium for
tein concentration, were immunoprecipitated with either DMT1(+IRE)
esolved by SDS–PAGE and immunoblotted with a streptavidin-HRP
T1(+IRE) protein were evident in cell lysates following iron-treatment
evels in iron treated cells (b). Densitometry data are means ± S.E.M. of
group.
Fig. 5. Intracellular localisation of DMT1 in Caco-2 cells. Caco-2 cells were subjected to subcellular fractionation on sucrose density gradients.
Fractions are numbered starting from the bottom of the tube (1 and 10 were not used for analysis). Equal volumes (25 ll) from each fraction were
resolved by SDS–PAGE. Western blotting of the isolated fractions revealed that DMT1(+IRE) mainly co-localised with LAMP1 a marker of late
endosomes/lysosomes, whereas DMT1(non-IRE) was largely associated with fractions containing EEA1, an early endosomal marker (a). In separate
studies, immunoprecipitation (IP) of post-plasma membrane whole cell lysates (adjusted to contain equal starting protein concentrations) with
LAMP1 and subsequent immunoblotting (IB) with anti-transporter antibodies revealed higher levels of DMT1(+IRE) in iron-treated cells compared
with controls (b). In contrast, DMT1(non-IRE) levels in LAMP1 precipitates from cells exposed to iron were not diﬀerent from untreated controls
(c). Furthermore, DMT1(+IRE) levels in EEA1 immunoprecipitates were unaltered by iron treatment (d). Densitometry data are means ± S.E.M. of
three to six observations in each group. *P < 0.01 compared with the control group.
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non-haem iron exerts a speciﬁc eﬀect on DMT1(+IRE) pro-
tein, traﬃcking the transporter away from the apical mem-
brane of intestinal epithelial cells. This decrease in membrane
protein expression is associated with an increase in transporter
levels within a late endosomal/lysosomal compartment.
The observation that whole cell DMT1 protein levels were
not reduced following 24 h exposure to iron (Fig. 2b) despite
a dramatic decrease in DMT1(+IRE) mRNA (Fig. 3) suggests
that the internalised transporter may be stored intracellularly
and is not targeted for immediate degradation within the lyso-
some. These ﬁndings are consistent with previous observations
of increased intracellular DMT1 in iron loaded animals [8,9].
Furthermore, this raises the prospect that DMT1(+IRE) pro-
tein might be recycled back to the cell surface when the iron
levels in the apical medium drop. To investigate this possibil-
ity, cells were treated with iron for 4 h. At the end of this
pre-incubation period, the iron was washed oﬀ and the cells
were placed in iron-free medium for a further 24 h during
which time changes in membrane DMT1(+IRE) protein levels
were monitored. Transporter protein returned to the original
baseline level (i.e. prior to iron treatment) within 8 h following
the removal of the iron challenge (Fig. 6a). Interestingly, there
were no changes in DMT1(+IRE) mRNA over this time peri-
od (Fig. 6b), suggesting that the mechanism of restoration was
post-transcriptional. To determine whether the observed in-
crease in DMT1(+IRE) protein at the cell surface required
de novo transporter synthesis, cells were treated with cyclohex-
imide. After 8 h in iron-free medium (following pre-incubationwith iron for 4 h) DMT1(+IRE) levels were not signiﬁcantly
diﬀerent in the control or cycloheximide-treated group
(Fig. 6c). These data favour a post-translational mechanism
involving transporter recycling from an intracellular localisa-
tion back to the plasma membrane when the iron concentra-
tion in the apical medium drops. It is unclear at this stage
whether the recycled DMT(+IRE) protein derives from the
intracellular pool that is associated with the late endosomal/
lysosomal compartment. Intriguingly, a recent study has
shown that proteins associated with the apical membrane in
T84 intestinal epithelial cells when endocytosed can be targeted
to a cellular compartment that is distinct from late or recycling
endosomes [29]. We cannot rule out the possibility that a sim-
ilar mechanism is involved in DMT1 recycling in Caco-2 cells.
In conclusion, our data suggest that the following cellular
mechanisms occur in response to an iron challenge. High levels
of iron presented to the apical surface of intestinal epithelial
cells induce traﬃcking of DMT1(+IRE) transporter protein
away from the apical membrane. This is associated with an in-
crease in transporter levels within an intracellular late endo-
somal/lysosomal compartment. Following removal of the iron
stimulus, DMT1(+IRE) is recycled back to the apical surface
where again it can participate in non-haem iron absorption.
These cellular changes in DMT1(+IRE) protein expression
occur rapidly (within a few hours) and prior to changes in
DMT1 mRNA levels. It is possible that the re-distribution of
DMT1 between diﬀerent cellular compartments could be
important physiologically, optimising iron absorption from a
meal so that it matches better the bodys metabolic
Fig. 6. Following the removal of iron, DMT1(+IRE) is recycled back
to the cell membrane. To determine the fate of DMT1(+IRE)
following the removal of the iron challenge, cells were incubated with
iron (100 lM) for 4 h (i.e. between t = 4 and 0 h). At the end of this
incubation period, cells were placed in iron-free medium (indicated by
the arrow) and DMT1(+IRE) protein levels in the plasma membrane
monitored over the next 24 h. Membrane levels of transporter protein
were restored to baseline levels (i.e., prior to incubation with iron) 4–
8 h following the removal of the iron challenge (a). In parallel studies
PCR analysis revealed that there was no change in DMT1(+IRE)
mRNA expression over this time period (b). To determine whether de
novo synthesis of transporter protein was required for restoration of
DMT1(+IRE) levels, some cells were treated with the protein synthesis
inhibitor cycloheximide (10 lg/ml). Following a 4 h pre-incubation
with iron, cells were placed in iron-free medium for 8 h (the time
required for maximal recovery of plasma membrane transporter
protein levels). There was no signiﬁcant diﬀerence in plasma membrane
DMT1(+IRE) protein expression between control and cycloheximide-
treated cells at this time (c). Data are means ± S.E.M. of four to six
separate determinations at each time point. *P < 0.05 compared with
the baseline value for DMT1(+IRE) expression (i.e., at t = 4 h) (one-
way ANOVA and Tukeys post hoc test).
1928 D.M. Johnson et al. / FEBS Letters 579 (2005) 1923–1929requirements. However, the precise purpose of this mechanism
remains to be established.
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